Pharmacokinetic performance of the nitrendipine intravenous submicron emulsion in rats
暂无分享,去创建一个
[1] K. Shi,et al. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability. , 2012, International journal of pharmaceutics.
[2] Jin Sun,et al. Formulation and preparation of a nitrendipine submicron emulsion , 2011 .
[3] F. Cui,et al. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] Dongmei Cun,et al. Effect of Crystal Size on the In Vitro Dissolution and Oral Absorption of Nitrendipine in Rats , 2010, Pharmaceutical Research.
[5] Jin Sun,et al. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. , 2010, International journal of pharmaceutics.
[6] Ying Ao,et al. Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats. , 2009, European journal of pharmacology.
[7] Feng Qin,et al. Determination of nimodipine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and pharmacokinetic application. , 2008, Journal of pharmaceutical and biomedical analysis.
[8] K. Bhaskar,et al. Development of Nitrendipine Controlled Release Formulations Based on SLN and NLC for Topical Delivery: In Vitro and Ex Vivo Characterization , 2008 .
[9] Jin Sun,et al. Preparation and Characterization of a Submicron Lipid Emulsion of Docetaxel: Submicron Lipid Emulsion of Docetaxel , 2008, Drug development and industrial pharmacy.
[10] Jin Sun,et al. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. , 2008, Drug development and industrial pharmacy.
[11] H. Sunada,et al. Improvement of the dissolution rate of nitrendipine using a new pulse combustion drying method. , 2007, Chemical & pharmaceutical bulletin.
[12] S. Kawakami,et al. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice. , 2006, International journal of pharmaceutics.
[13] V. Venkateswarlu,et al. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration , 2006, Journal of drug targeting.
[14] H. Sunada,et al. Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder. , 2005, Chemical & pharmaceutical bulletin.
[15] Y. Kawashima,et al. In Vivo Evaluation of Two Novel Controlled-Release Nitrendipine Formulations , 2005, Drug development and industrial pharmacy.
[16] I. Niopas,et al. Determination of nifedipine in human plasma by solid-phase extraction and high-performance liquid chromatography: validation and application to pharmacokinetic studies. , 2003, Journal of pharmaceutical and biomedical analysis.
[17] Dae-Duk Kim,et al. Improvement of Dissolution and Bioavailability of Nitrendipine by Inclusion in Hydroxypropyl-β-cyclodextrin , 2003, Drug development and industrial pharmacy.
[18] K. Goa,et al. Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. , 1987, Drugs.
[19] B. Bean,et al. Nitrendipine Block of Calcium Channels in Cardiac and Vascular Muscle , 1987 .
[20] J. Lettieri,et al. Disposition and Pharmacokinetics of 14C‐Nitrendipine in Healthy Volunteers , 1987 .
[21] M. Singh,et al. Parenteral emulsions as drug carrier systems. , 1986, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[22] J. Lauwo. Effect of Particle Size and Excipients on the Dissolution Rate of Metronidazole from Solid Dosage Forms: II , 1984 .